Vault-13

TYBOURNE CAPITAL MANAGEMENT (HK) LTD

HONG KONG, K3 · CIK 1553936 · 13F filing filed 2022-08-15

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$1.4bn reported value -18.0% vs Q1 2022
27positions
62.5%in top 10
0 new 10 added 0 reduced 3 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 MICROSOFT CORP COM MSFT MSFT 437,400 $112.3m8.11% 8.11% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 437.4k, Q2 2022 437.4k
2 CANADIAN PAC RY LTD COM COM 1,588,392 $110.9m8.01% 8.01% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.2m, Q2 2022 1.6m +437.7k +437,671 38.0%
3 AMAZON COM INC COM AMZN AMZN 1,012,000 $107.5m7.76% 7.76% AddedShares held: Q3 2021 1.3m, Q4 2021 1.8m, Q1 2022 816.1k, Q2 2022 1.0m +195.9k +195,925 24.0%
4 VISA INC COM CL A V V 511,651 $100.7m7.28% 7.28% AddedShares held: Q3 2021 1.1m, Q4 2021 1.0m, Q1 2022 481.9k, Q2 2022 511.7k +29.8k +29,751 6.2%
5 S&P GLOBAL INC COM SPGI SPGI 267,800 $90.3m6.52% 6.52% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 200.1k, Q2 2022 267.8k +67.7k +67,700 33.8%
6 KE HLDGS INC SPONSORED ADS BEKE BEKE 4,410,552 $79.2m5.72% 5.72% AddedShares held: Q3 2021 16.4m, Q4 2021 16.1m, Q1 2022 4.1m, Q2 2022 4.4m +315.5k +315,469 7.7%
7 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 2,426,095 $68.2m4.92% 4.92% UnchangedShares held: Q3 2021 2.7m, Q4 2021 2.6m, Q1 2022 2.4m, Q2 2022 2.4m
8 H WORLD GROUP LTD SPONSORED ADS HTHT HTHT 1,779,109 $67.8m4.90% 4.90% AddedShares held: Q3 2021 0, Q4 2021 1.3m, Q1 2022 834.0k, Q2 2022 1.8m +945.1k +945,100 113.3%
9 MERCADOLIBRE INC COM MELI MELI 105,431 $67.1m4.85% 4.85% AddedShares held: Q3 2021 207.7k, Q4 2021 261.8k, Q1 2022 89.4k, Q2 2022 105.4k +16.0k +16,000 17.9%
10 LINDE PLC SHS 99952EUR 99952EUR 215,347 $61.9m4.47% 4.47% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 215.3k, Q2 2022 215.3k
11 SEA LTD SPONSORD ADS SE SE 867,326 $58.0m4.19% 4.19% AddedShares held: Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 609.7k, Q2 2022 867.3k +257.6k +257,596 42.2%
12 SHOPIFY INC CL A SHOP SHOP 1,466,670 $45.8m3.31% 3.31% AddedShares held: Q3 2021 1.4m, Q4 2021 1.3m, Q1 2022 940.0k, Q2 2022 1.5m +526.7k +526,670 56.0%
13 TEXAS INSTRS INC COM TXN TXN 289,200 $44.4m3.21% 3.21% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 289.2k, Q2 2022 289.2k
14 QUALCOMM INC COM QCOM QCOM 346,800 $44.3m3.20% 3.20% UnchangedShares held: Q3 2021 0, Q4 2021 363.4k, Q1 2022 346.8k, Q2 2022 346.8k
15 LAM RESEARCH CORP COM COM 101,000 $43.0m3.11% 3.11% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 101.0k, Q2 2022 101.0k
16 TWILIO INC CL A TWLO TWLO 504,324 $42.3m3.05% 3.05% AddedShares held: Q3 2021 480.0k, Q4 2021 570.1k, Q1 2022 236.4k, Q2 2022 504.3k +267.9k +267,900 113.3%
17 BLOCK INC CL A XYZ XYZ 625,900 $38.5m2.78% 2.78% UnchangedShares held: Q3 2021 941.4k, Q4 2021 903.2k, Q1 2022 625.9k, Q2 2022 625.9k
18 ATLASSIAN CORP PLC CL A CL A 192,100 $36.0m2.60% 2.60% UnchangedShares held: Q3 2021 517.2k, Q4 2021 183.0k, Q1 2022 192.1k, Q2 2022 192.1k
19 MONGODB INC CL A MDB MDB 132,000 $34.3m2.47% 2.47% UnchangedShares held: Q3 2021 584.5k, Q4 2021 376.5k, Q1 2022 132.0k, Q2 2022 132.0k
20 STONECO LTD COM CL A STNE STNE 3,857,463 $29.7m2.15% 2.15% UnchangedShares held: Q3 2021 5.8m, Q4 2021 5.8m, Q1 2022 3.9m, Q2 2022 3.9m
21 SNOWFLAKE INC CL A SNOW SNOW 183,600 $25.5m1.84% 1.84% UnchangedShares held: Q3 2021 959.7k, Q4 2021 514.0k, Q1 2022 183.6k, Q2 2022 183.6k
22 NVIDIA CORPORATION COM NVDA NVDA 161,600 $24.5m1.77% 1.77% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 161.6k, Q2 2022 161.6k
23 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 1,154,126 $19.4m1.40% 1.40% UnchangedShares held: Q3 2021 2.0m, Q4 2021 2.1m, Q1 2022 1.2m, Q2 2022 1.2m
24 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 768,603 $14.8m1.07% 1.07% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 768.6k, Q2 2022 768.6k
25 INHIBRX INC COM INBX INBX 794,682 $9.0m0.65% 0.65% UnchangedShares held: Q3 2021 1.0m, Q4 2021 1.0m, Q1 2022 794.7k, Q2 2022 794.7k
26 LIANBIO SPONSORED ADS LIANY LIANY 3,314,173 $7.2m0.52% 0.52% UnchangedShares held: Q3 2021 0, Q4 2021 3.3m, Q1 2022 3.3m, Q2 2022 3.3m
27 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 500,000 $1.9m0.13% 0.13% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
EQRX INC 2,286,735 $9.4m2.3m shares
RENEO PHARMACEUTICALS INC 700,000 $2.1m700.0k shares
EXICURE INC XCUR XCUR 7,325,000 $1.5m7.3m shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
FORTE BIOSCIENCES INC FBRX · 13G · filed 2025-08-04 FBRX 10.0%≈ $26.9m no change 13G 2025-08-04